WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006079656) HIV INHIBITING 2-( 4-CYANOPHENYLAMINO) PYRIMIDINE DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/079656    International Application No.:    PCT/EP2006/050490
Publication Date: 03.08.2006 International Filing Date: 27.01.2006
IPC:
C07D 239/50 (2006.01), C07D 239/48 (2006.01), A61K 31/505 (2006.01), A61P 31/18 (2006.01)
Applicants: TIBOTEC PHARMACEUTICALS LTD. [IE/IE]; Eastgate Village, Eastgate, Little Island, Co Cork (IE) (For All Designated States Except US).
HEERES, Jan [NL/BE]; (BE) (For US Only).
LEWI, Paulus Joannes [BE/BE]; (BE) (For US Only).
ARTS, Frank Xavier Jozef Herwig [BE/BE]; (BE) (For US Only).
LEEMANS, Rudolf [NL/BE]; (BE) (For US Only).
MOENS, Luc Jozef Raphael [BE/BE]; (BE) (For US Only)
Inventors: HEERES, Jan; (BE).
LEWI, Paulus Joannes; (BE).
LEEMANS, Rudolf; (BE).
MOENS, Luc Jozef Raphael; (BE).
JANSSEN, Paul Adriaan Jan;
Agent: WANTE, Dirk; Tibotec-Virco Comm. VA, Generaal De Wittelaan L 11b 3, B-2800 Mechelen (BE)
Priority Data:
05100521.3 27.01.2005 EP
Title (EN) HIV INHIBITING 2-( 4-CYANOPHENYLAMINO) PYRIMIDINE DERIVATIVES
(FR) DERIVES 2-( 4-CYANOPHENYLAMINO) DE LA PYRIMIDINE, INHIBITEURS DU VIH
Abstract: front page image
(EN)HIV replication inhibitors of formula (I) pharmaceut ically acceptable addition salts or stereochemically isomeric forms thereof, wherein X is NR4, S, SO or SO2; the preparation of these compounds as well as pharmaceutical compositions comprising these compounds; the use of these compounds for the prevention or the treatment of HIV infection.
(FR)L'invention porte sur des inhibiteurs de réplication du VIH de formule (I) dans laquelle: X est NR4, S, SO ou SO2; sur leurs sels d'addition pharmacocompatibles, ou leurs isomères stéréochimiques; sur leur préparation, sur des préparations pharmaceutiques les contenant; et sur leur utilisation pour la prévention ou le traitement des infections par le VIH.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)